<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00493961</url>
  </required_header>
  <id_info>
    <org_study_id>U54HD028138-447</org_study_id>
    <secondary_id>U54HD028138</secondary_id>
    <nct_id>NCT00493961</nct_id>
  </id_info>
  <brief_title>Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism</brief_title>
  <official_title>The Effects of 7 Days of Exogenous Pulsatile GnRH Treatment on the Pituitary-Gonadal Axis in Hypogonadotropic Hypogonadal Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>William F. Crowley, Jr., M.D.</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Men with Idiopathic Hypogonadotropic Hypogonadism (IHH) lack a hormone called gonadotropin
      releasing hormone (GnRH). This hormone is important for starting puberty, maintaining
      testosterone levels, and fertility. The purpose of this study is to research the effects of
      treating IHH men with GnRH for 7 days.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite variability in the triggers, timing, and pace of sexual maturity between species, all
      species utilize the final pathway of hypothalamic secretion of gonadotropin releasing hormone
      (GnRH) to initiate and maintain the reproductive axis. Thus, GnRH is required for
      reproductive competence in the human. The classic studies from the 1970s clearly demonstrate
      that pulsatile release of GnRH from the hypothalamus is a prerequisite for physiologic
      gonadotrope function. Absence, decreased frequency or decreased amplitude of pulsatile GnRH
      release results in the clinical syndrome of hypogonadotropic hypogonadism (HH). The
      phenotypic expression of GnRH deficiency in the human demonstrates considerable
      heterogeneity. Defining the physiology of GnRH is critical to understanding the clinical
      heterogeneity of isolated GnRH deficiency and its comparison to other conditions resulting in
      hypogonadotropic hypogonadism (HH). The overall goal of this protocol is to investigate the
      neuroendocrine control of reproduction and specifically the physiology and pathophysiology of
      GnRH secretion and action in the human male.

      Subjects will be selected from a group of adult men (18-65 years)based on the demonstration
      of a low testosterone level (&lt;100 ng/dL) in association with low or inappropriately normal
      gonadotropin levels. All patients will undergo an initial assessment that includes an
      overnight 12-hour frequent blood sampling study to determine their degree of endogenous GnRH
      secretion. Following the overnight evaluation, subjects will have daily outpatient visits for
      7 consecutive days when they will receive a GnRH bolus followed by 2hrs of blood sampling.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 1999</start_date>
  <completion_date type="Anticipated">May 2025</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>testosterone</measure>
    <time_frame>daily for 7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>LH</measure>
    <time_frame>frequent sampling for 2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>FSH</measure>
    <time_frame>frequent sampling for 2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Inhibin B</measure>
    <time_frame>daily for 7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>free alpha subunit</measure>
    <time_frame>daily for 7 days</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Kallmann Syndrome</condition>
  <condition>Idiopathic Hypogonadotropic Hypogonadism</condition>
  <condition>GnRH Deficiency</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>gonadotropin releasing hormone (GnRH)</intervention_name>
    <description>Pulsatile GnRH (25 ng/kg per bolus every two hours via microinfusion pump)</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of idiopathic hypogonadotropic hypogonadism (IHH) or Kallmann syndrome
             (KS)Adult male 18-65 years of age

          -  Serum testosterone &lt;100 ng/dL

        Exclusion Criteria:

          -  No specific exclusion criteria
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William F Crowley, Jr., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114-2696</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.massgeneral.org/reproendo/pages/reu_study_subject.htm</url>
    <description>Clinical research studies of the Reproductive Endocrine Unit at the Massachusetts General Hospital. Click here for more information about this study: Effects of Seven Days of Exogenous Pulsatile GnRH Treatment...</description>
  </link>
  <reference>
    <citation>Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science. 1978 Nov 10;202(4368):631-3.</citation>
    <PMID>100883</PMID>
  </reference>
  <reference>
    <citation>Seminara SB, Hayes FJ, Crowley WF Jr. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr Rev. 1998 Oct;19(5):521-39. Review.</citation>
    <PMID>9793755</PMID>
  </reference>
  <reference>
    <citation>Arimura A, Kastin AJ, Gonzalez-Barcena D, Siller J, Weaver RE, Schally AV. Disappearance of LH-releasing hormone in man as determined by radioimmunoassay. Clin Endocrinol (Oxf). 1974 Oct;3(4):421-5.</citation>
    <PMID>4609640</PMID>
  </reference>
  <reference>
    <citation>Pimstone B, Epstein S, Hamilton SM, LeRoith D, Hendricks S. Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure. J Clin Endocrinol Metab. 1977 Feb;44(2):356-60.</citation>
    <PMID>320223</PMID>
  </reference>
  <reference>
    <citation>Clarke IJ, Cummins JT. The temporal relationship between gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) secretion in ovariectomized ewes. Endocrinology. 1982 Nov;111(5):1737-9.</citation>
    <PMID>6751801</PMID>
  </reference>
  <reference>
    <citation>Karsch FJ, Bowen JM, Caraty A, Evans NP, Moenter SM. Gonadotropin-releasing hormone requirements for ovulation. Biol Reprod. 1997 Feb;56(2):303-9. Review.</citation>
    <PMID>9116125</PMID>
  </reference>
  <reference>
    <citation>Spratt DI, O'Dea LS, Schoenfeld D, Butler J, Rao PN, Crowley WF Jr. Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am J Physiol. 1988 May;254(5 Pt 1):E658-66.</citation>
    <PMID>3129947</PMID>
  </reference>
  <reference>
    <citation>Hayes FJ, McNicholl DJ, Schoenfeld D, Marsh EE, Hall JE. Free alpha-subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequencies. J Clin Endocrinol Metab. 1999 Mar;84(3):1028-36.</citation>
    <PMID>10084591</PMID>
  </reference>
  <reference>
    <citation>Hoffman AR, Crowley WF Jr. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. N Engl J Med. 1982 Nov 11;307(20):1237-41.</citation>
    <PMID>6813732</PMID>
  </reference>
  <reference>
    <citation>Whitcomb RW, Crowley WF Jr. Clinical review 4: Diagnosis and treatment of isolated gonadotropin-releasing hormone deficiency in men. J Clin Endocrinol Metab. 1990 Jan;70(1):3-7. Review.</citation>
    <PMID>2403572</PMID>
  </reference>
  <reference>
    <citation>Filippi G. Klinefelter's syndrome in Sardinia. Clinical report of 265 hypogonadic males detected at the time of military check-up. Clin Genet. 1986 Oct;30(4):276-84.</citation>
    <PMID>3791676</PMID>
  </reference>
  <reference>
    <citation>Fromantin M, Gineste J, Didier A, Rouvier J. [Impuberism and hypogonadism at induction into military service. Statistical study]. Probl Actuels Endocrinol Nutr. 1973 May 3;16:179-99. French.</citation>
    <PMID>4147392</PMID>
  </reference>
  <reference>
    <citation>Filicori M, Butler JP, Crowley WF Jr. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest. 1984 Jun;73(6):1638-47.</citation>
    <PMID>6427277</PMID>
  </reference>
  <reference>
    <citation>Narasimha Rao P, Moore PH Jr. Synthesis of new steroid haptens for radioimmunoassay. Part I. 15beta-Carboxyethylmercaptotestosterone-bovine serum albumin conjugate. Measurement of testosterone in male plasma without chromatography. Steroids. 1976 Jul;28(1):101-9.</citation>
    <PMID>960143</PMID>
  </reference>
  <reference>
    <citation>Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP, McNeilly AS. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 1996 Apr;81(4):1401-5.</citation>
    <PMID>8636341</PMID>
  </reference>
  <reference>
    <citation>Landy H, Schneyer AL, Whitcomb RW, Crowley WF Jr. Validation of highly specific and sensitive radioimmunoassays for lutropin, follitropin, and free alpha subunit in unextracted urine. Clin Chem. 1990 Feb;36(2):340-4.</citation>
    <PMID>2105862</PMID>
  </reference>
  <results_reference>
    <citation>Pitteloud N, Thambundit A, Dwyer AA, Falardeau JL, Plummer L, Caronia LM, Hayes FJ, Lee H, Boepple PA, Crowley WF Jr. Role of seminiferous tubular development in determining the FSH versus LH responsiveness to GnRH in early sexual maturation. Neuroendocrinology. 2009;90(3):260-8. doi: 10.1159/000245383. Epub 2009 Oct 15.</citation>
    <PMID>19829004</PMID>
  </results_reference>
  <results_reference>
    <citation>Sykiotis GP, Hoang XH, Avbelj M, Hayes FJ, Thambundit A, Dwyer A, Au M, Plummer L, Crowley WF Jr, Pitteloud N. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab. 2010 Jun;95(6):3019-27. doi: 10.1210/jc.2009-2582. Epub 2010 Apr 9.</citation>
    <PMID>20382682</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2007</study_first_submitted>
  <study_first_submitted_qc>June 28, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2007</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</investigator_affiliation>
    <investigator_full_name>William F. Crowley, Jr., M.D.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Kallmann Syndrome</keyword>
  <keyword>Idiopathic Hypogonadotropic Hypogonadism</keyword>
  <keyword>GnRH deficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypogonadism</mesh_term>
    <mesh_term>Kallmann Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

